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ABSTRACT 
HBcAg (hepatitis B core antigen) is a nanoplex bioproduct that has a great potential in the 
development of therapeutic drugs and vaccines. In the present study, a continuous-flow bead 
milling for the disruption of Escherichia coli was optimized and a direct recovery protocol to 
isolate the recombinant HBcAg from the unclarified E. coli disruptate was developed. The 
optimal condition for continuous-flow bead milling for the release of HBcAg from E. coli 
was achieved at a feed flow rate of 15 litres/h, biomass concentration of 10% [ww/v (wet 
weight/vol.)] and impeller tip speed of 14 m/s. The sucrose-density-gradient analysis showed 
that the particulate form of the HBcAg released by this optimal condition is still preserved. In 
the direct purification of HBcAg from the unclarified disruptate, the AE-EBAC (anion-
exchange expanded-bed adsorption chromatography) technique was employed. A 54% 
adsorption and 50.7% recovery of HBcAg were achieved in this direct recovery process. The 
purity of HBcAg recovered was 49.8%, which corresponds to a purification factor of 2.0. 
ELISA showed that the HBcAg recovered is functionally active.  
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